Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
19.34
+0.68 (3.64%)
Dec 20, 2024, 4:00 PM EST - Market closed
Forte Biosciences Analyst Ratings
Total Analysts
3
Consensus Rating
Strong Buy
Price Target
$77.58
Upside
+301.14%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $64 | Strong Buy | Maintains | $64 | +230.92% | Dec 4, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $3 → $64 | Strong Buy | Maintains | $3 → $64 | +230.92% | Nov 15, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $75 | Strong Buy | Maintains | $75 | +287.80% | Aug 19, 2024 |
| Brookline Capital | Brookline Capital | Strong Buy Initiates $100 | Strong Buy | Initiates | $100 | +417.06% | May 30, 2024 |
| Ladenburg Thalmann | Ladenburg Thalmann | Hold → Strong Buy Upgrades $69 | Hold → Strong Buy | Upgrades | $69 | +255.48% | Apr 8, 2024 |
| Chardan Capital | Chardan Capital | Strong Sell → Hold Upgrades $100 → $88 | Strong Sell → Hold | Upgrades | $100 → $88 | +352.43% | Sep 20, 2021 |
| Brookline Capital | Brookline Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 3, 2021 |
| Chardan Capital | Chardan Capital | Strong Buy → Strong Sell Downgrades $100 | Strong Buy → Strong Sell | Downgrades | $100 | +417.06% | Sep 3, 2021 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 3, 2021 |
| B. Riley Securities | B. Riley Securities | Strong Buy → Hold Downgrades $75 | Strong Buy → Hold | Downgrades | $75 | +287.80% | Sep 3, 2021 |
| Truist Securities | Truist Securities | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 3, 2021 |
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates $1,825 | Strong Buy | Initiates | $1,825 | +9,336.40% | May 14, 2021 |
| Citigroup | Citigroup | Strong Buy Initiates $1,875 | Strong Buy | Initiates | $1,875 | +9,594.93% | Mar 26, 2021 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $2,875 → $2,625 | Strong Buy | Maintains | $2,875 → $2,625 | +13,472.91% | Mar 17, 2021 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $1,500 → $2,750 | Strong Buy | Maintains | $1,500 → $2,750 | +14,119.23% | Sep 24, 2020 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $1,125 → $1,500 | Strong Buy | Maintains | $1,125 → $1,500 | +7,655.95% | Sep 10, 2020 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.